WG
BLUE

Winton Group’s bluebird bio BLUE Stock Holding History

Winton Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,541
Closed -$128K – 953
2022
Q2 		$128K Buy
+1,541
New +$120K 0.01% 916
2018
Q4 		– Sell
-113
Closed -$214K – 875
2018
Q3 		$214K Sell
113
-25
-18% -$51.6K ﹤0.01% 949
2018
Q2 		$281K Sell
138
-56
-29% -$128K 0.01% 855
2018
Q1 		$429K Buy
+194
New +$493K 0.01% 844

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Winton Group's BLUE Position: Q3 2022 in Review

Winton Group sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 1,541 shares — an estimated $128K sold.

Winton Group first reported a position in BLUE in Q1 2018 and held it in 4 quarters. The position peaked at $429K in Q1 2018. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

  • Winton Group reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
  • Winton Group sold 1,541 bluebird bio shares in Q3 2022, an estimated $128K.
  • Winton Group first reported a position in bluebird bio in Q1 2018 and held it in 4 quarters.
  • Winton Group's bluebird bio position peaked at $429K in Q1 2018.
  • 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Winton Group's 13F filing for Q3 2022, filed 10 Nov 2022.